Summit Therapeutics Inc (SMMT)

10:06 AM

Bernstein reiterates Summit Therapeutics stock Underperform rating By Investing.com - Investing.com Canada

10:06 AM

May 25, 2026

Summit Therapeutics Inc. (SMMT) Stock Analysis: Biotech Player With 72% Potential Upside - DirectorsTalk Interviews

May 25, 2026

May 23, 2026

Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally - The Motley Fool

May 23, 2026

May 23, 2026

Bernstein initiates coverage of Summit Therapeutics (SMMT) with underperform recommendation - MSN

May 23, 2026

May 23, 2026

HC Wainwright & Co. downgrades Summit Therapeutics (SMMT) - MSN

May 23, 2026

May 23, 2026

SUPERSTRING CAPITAL MANAGEMENT LP's Summit Therapeutics Inc(SMMT) Holding History - GuruFocus

May 23, 2026

May 22, 2026

Summit Therapeutics Analyst Ratings and Price Targets | NASDAQ:SMMT - Benzinga

May 22, 2026

May 22, 2026

SMMT Initiates Coverage On Summit Therapeutics -- Rating Underpe - GuruFocus

May 22, 2026

May 22, 2026

Summit Therapeutics (SMMT) Faces Downgrade Amidst Competitive Pr - GuruFocus

May 22, 2026

May 22, 2026

Summit Therapeutics (SMMT) Downgraded to Neutral Amid Competitiv - GuruFocus

May 22, 2026

May 22, 2026

SMMT Downgraded by HC Wainwright & Co. -- Rating Changes to Neut - GuruFocus

May 22, 2026

May 22, 2026

Summit Therapeutics Shares Fall After HC Wainwright Downgrade - marketscreener.com

May 22, 2026

May 22, 2026

This Summit Therapeutics Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For FridayCentene (NY - Benzinga

May 22, 2026

May 22, 2026

Summit downgraded at H.C. Wainwright after Merck data for sac-TMT - Seeking Alpha

May 22, 2026

May 22, 2026

Summit Therapeutics Price Target Announced at $7.70/Share by Bernstein - Moomoo

May 22, 2026

May 22, 2026

Why is Summit Therapeutics stock sliding today? By Investing.com - Investing.com Canada

May 22, 2026

May 22, 2026

Here's Why You Should Add SMMT Stock to Your Portfolio Now - Yahoo Finance

May 22, 2026

May 22, 2026

Cantor Fitzgerald reiterates Overweight on Summit Therapeutics stock By Investing.com - Investing.com Canada

May 22, 2026

May 22, 2026

S&P 500 Futures Climb In Premarket Trading; WR Berkley, Summit Therapeutics Lag - Moomoo

May 22, 2026

May 22, 2026

H.C. Wainwright downgrades Summit Therapeutics stock rating to neutral By Investing.com - Investing.com Canada

May 22, 2026

May 22, 2026

Bernstein Initiates Summit Therapeutics at Underperform - Moomoo

May 22, 2026

May 22, 2026

HC Wainwright Downgrades Summit Therapeutics to Neutral From Buy - Moomoo

May 22, 2026

May 22, 2026

H.C. Wainwright Downgrades Summit Therapeutics(SMMT.US) to Hold Rating - Moomoo

May 22, 2026

May 21, 2026

Summit Therapeutics (SMMT) Faces Scrutiny with Underperform Rati - GuruFocus

May 21, 2026

May 21, 2026

Bernstein downgrades Summit Therapeutics stock rating on trial concerns By Investing.com - Investing.com Canada

May 21, 2026

May 20, 2026

SMMT Technical Analysis | Trend, Signals & Chart Patterns | SUMMIT THERAPEUTICS INC (NASDAQ:SMMT) - ChartMill

May 20, 2026

May 18, 2026

Summit Therapeutics Inc.Common Stock (NQ: SMMT - The Chronicle-Journal

May 18, 2026

May 18, 2026

Cancer Stocks That Are Advancing the Future of Oncology Care - Yahoo! Finance Canada

May 18, 2026

May 18, 2026

Summit Therapeutics Inc. (SMMT) Stock Analysis: Healthcare Innovator with Potential 74% Upside - DirectorsTalk Interviews

May 18, 2026

May 17, 2026

(SMMT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

May 17, 2026

May 15, 2026

A Look At Summit Therapeutics (SMMT) Valuation After HARMONi-3 Trial Risk Highlighted By Analyst Commentary - Yahoo Finance

May 15, 2026

May 13, 2026

H.C. Wainwright Reduced its Price Goal on Summit Therapeutics Inc. (SMMT) - Insider Monkey

May 13, 2026

May 12, 2026

Summit Therapeutics falls after update on Akeso-partnered lung cancer trial - MSN

May 12, 2026

May 12, 2026

8 Most Promising Biotech Stocks to Buy Now - Insider Monkey

May 12, 2026

May 11, 2026

Summit Therapeutics (SMMT) Is Down 20.1% After Q1 2026 Net Loss Widens Sharply - simplywall.st

May 11, 2026

May 08, 2026

Summit Therapeutics Inc (SMMT) News, Articles, Events & Latest Updates - Stocktwits

May 08, 2026

May 08, 2026

Q2 EPS Estimate for Summit Therapeutics Boosted by Analyst - MarketBeat

May 08, 2026

May 07, 2026

Q2 Earnings Forecast for SMMT Issued By HC Wainwright - MarketBeat

May 07, 2026

May 06, 2026

How (SMMT) Movements Inform Risk Allocation Models - Stock Traders Daily

May 06, 2026

May 05, 2026

JPM: AKESO (09926.HK) Lung Cancer Trial Final Analysis Likely to Meet Target; Rating Overweight - AASTOCKS.com

May 05, 2026

May 05, 2026

How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III - BioWorld News

May 05, 2026

May 04, 2026

SMMT Q1 Loss Narrower Than Expected, Stock Down on Ivonescimab Setback - Yahoo Finance

May 04, 2026

May 04, 2026

Summit Therapeutics: More Uncertainty Heading Into The ASCO Plenary (NASDAQ:SMMT) - Seeking Alpha

May 04, 2026

May 04, 2026

Investigation into Summit Therapeutics by Johnson Fistel - Intellectia AI

May 04, 2026

May 04, 2026

Summit Therapeutics Inc. Shareholders Are Encouraged to - GlobeNewswire

May 04, 2026

May 04, 2026

SMMT Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus

May 04, 2026

May 04, 2026

H.C. Wainwright cuts Summit Therapeutics stock price target on trial risk - Investing.com Canada

May 04, 2026

May 04, 2026

H.C. Wainwright Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Cuts Target Price to $23 - Moomoo

May 04, 2026

May 04, 2026

We're Hopeful That Summit Therapeutics (NASDAQ:SMMT) Will Use Its Cash Wisely - Yahoo Finance

May 04, 2026

May 04, 2026

Summit Therapeutics Inc. (SMMT) Stock Analysis: Promising 91% Upside in the Biotech Sector - DirectorsTalk Interviews

May 04, 2026

May 03, 2026

Biopharmaceutical News: Summit Therapeutics Stock Plummets After Trial Analysis Misstep - geneonline.com

May 03, 2026

May 03, 2026

Analysts Offer Insights on Healthcare Companies: Adagene (ADAG) and Summit Therapeutics (SMMT) - The Globe and Mail

May 03, 2026

May 03, 2026

SMMT Plunges As Summit Therapeutics Stock Suffers 27% Selloff - StocksToTrade

May 03, 2026